Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 3/20 | 0.84 |
| ▸ | PNP | P00491 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | TP53 | P04637 | 1/20 | 0.73 |
| ▸ | HTT | P42858 | 1/20 | 0.73 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.73 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.73 |
| ▸ | POLB | P06746 | 2/20 | 0.61 |
| ▸ | P2RY1 | P47900 | 7/20 | 0.60 |
| ▸ | P2RY11 | Q96G91 | 2/20 | 0.60 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.57 |
| ▸ | CA5A | P35218 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27179019 | 1.00 | NT5E (0.84) | NT5EPNPLMNATP53HTT | |
| Ammonia Solution, Strong SCHEMBL10352165 | 1.00 | NT5E (0.84) | NT5EPNPLMNATP53HTT | |
| SCHEMBL10351553 | 1.00 | NT5E (0.84) | NT5EPNPLMNATP53HTT | |
| SCHEMBL10352151 | 0.99 | NT5E (0.83) | NT5EPNPLMNATP53HTT | |
| SCHEMBL10352160 | 0.93 | NT5E (0.79) | NT5EPNPLMNATP53HTT | |
| SCHEMBL8900163 | 0.93 | NT5E (0.79) | NT5EPNPLMNATP53HTT | |
| SCHEMBL10352355 | 0.92 | NT5E (0.79) | NT5EPNPLMNATP53HTT | |
| 2-Chlorodeoxyadenosine Triphosphate SCHEMBL1064481 | 0.92 | NT5E (0.78) | NT5EPNPLMNATP53HTT | |
| 2-Chlorodeoxyadenosine Triphosphate SCHEMBL29760737 | 0.92 | NT5E (0.78) | NT5EPNPLMNATP53HTT | |
| 2-Chlorodeoxyadenosine Triphosphate SCHEMBL1064487 | 0.92 | NT5E (0.78) | NT5EPNPLMNATP53HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1221609-A | Pharmaceutical use of adenosine phosphates and pharmaceutical preparation thereof | KARL Y HOSTETLER (US) | 1999-07-07 | — | — | CN | claimed |
| US-5654286-A | Nucleotides for topical treatment of psoriasis, and methods for using same | HOSTETLER KARL Y (US) | 1997-08-05 | — | — | US | claimed |
| EP-0190726-B1 | NOVEL DEOXYADENOSINE PHOSPHATE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | WARNER-LAMBERT COMPANY (US) | 1990-06-13 | — | — | EP | claimed |
| US-4908441-A | Deoxyadenosine compounds and methods of making and using the same | WARNER-LAMBERT COMPANY (US) | 1990-03-13 | — | — | US | claimed |
| EP-0351795-A2 | Novel deoxyadenosine compounds and methods of making and using the same | WARNER-LAMBERT COMPANY (US) | 1990-01-24 | — | — | EP | claimed |
| US-4826823-A | MICROBIOCIDES, VIRICIDES | WARNER-LAMBERT COMPANY (US) | 1989-05-02 | — | — | US | claimed |
| EP-0190726-A2 | Novel deoxyadenosine phosphate compounds and methods of making and using the same | WARNER-LAMBERT COMPANY (US) | 1986-08-13 | — | — | EP | claimed |
| EP-2428201-A1 | Oral administration of nucleoside monophosphates | Merck Serono S.A. (CH) | 2012-03-14 | — | — | EP | disclosed |
| CN-1221609-A | Pharmaceutical use of adenosine phosphates and pharmaceutical preparation thereof | KARL Y HOSTETLER (US) | 1999-07-07 | — | — | CN | disclosed |
| CN-1221609-A | Pharmaceutical use of adenosine phosphates and pharmaceutical preparation thereof | KARL Y HOSTETLER (US) | 1999-07-07 | — | — | CN | disclosed |
| CN-1220605-A | Nucleotide analogues for topical treatment of skin cell proliferative disorders | KARL Y HOSTETLER (US) | 1999-06-23 | — | — | CN | disclosed |
| EP-0831855-A1 | NUCLEOTIDE ANALOGUES FOR TOPICAL TREATMENT OF PROLIFERATIVE DISEASE OF THE SKIN | HOSTETLER, Karl Y. (US) | 1998-04-01 | — | — | EP | disclosed |
| US-5661136-A | 2-halo-2'-fluoro ARA adenosines as antinoplastic agents | SOUTHERN RESEARCH INSTITUTE (US) | 1997-08-26 | — | — | US | disclosed |
| EP-0351795-A2 | Novel deoxyadenosine compounds and methods of making and using the same | WARNER-LAMBERT COMPANY (US) | 1990-01-24 | — | — | EP | disclosed |
| US-4826823-A | MICROBIOCIDES, VIRICIDES | WARNER-LAMBERT COMPANY (US) | 1989-05-02 | — | — | US | disclosed |
| US-4826823-A | MICROBIOCIDES, VIRICIDES | WARNER-LAMBERT COMPANY (US) | 1989-05-02 | — | — | US | disclosed |
| US-4826823-A | MICROBIOCIDES, VIRICIDES | WARNER-LAMBERT COMPANY (US) | 1989-05-02 | — | — | US | disclosed |
| US-4719295-A | ANTIMICROBIAL, ANTIVIRAL, ANTILEUKEMIA | WARNER-LAMBERT COMPANY (US) | 1988-01-12 | — | — | US | disclosed |
| EP-0190726-A2 | Novel deoxyadenosine phosphate compounds and methods of making and using the same | WARNER-LAMBERT COMPANY (US) | 1986-08-13 | — | — | EP | disclosed |
| EP-0190726-A2 | Novel deoxyadenosine phosphate compounds and methods of making and using the same | WARNER-LAMBERT COMPANY (US) | 1986-08-13 | — | — | EP | disclosed |